欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Imuldosa	Human	ustekinumab	ustekinumab	EMEA/H/C/006221	Accord Healthcare S.L.U.	2024/12/12	Authorised
Absimky	Human	ustekinumab	ustekinumab	EMEA/H/C/006585	Accord Healthcare S.L.U.	2024/12/12	Authorised
Fymskina	Human	ustekinumab	ustekinumab	EMEA/H/C/005805	Formycon AG	2024/09/25	Authorised
Otulfi	Human	ustekinumab	ustekinumab	EMEA/H/C/006544	Fresenius Kabi Deutschland GmbH	2024/09/25	Authorised
Eksunbi	Human	ustekinumab	ustekinumab	EMEA/H/C/006448	Samsung Bioepis NL B.V.	2024/09/12	Authorised
Steqeyma	Human	ustekinumab	ustekinumab	EMEA/H/C/005918	Celltrion Healthcare Hungary Kft.	2024/08/22	Authorised
Wezenla	Human	ustekinumab	ustekinumab	EMEA/H/C/006132	Amgen Technology (Ireland) UC	2024/06/20	Authorised
Pyzchiva	Human	ustekinumab	ustekinumab	EMEA/H/C/006183	Samsung Bioepis NL B.V.	2024/04/19	Authorised
Uzpruvo	Human	ustekinumab	ustekinumab	EMEA/H/C/006101	Stada Arzneimittel AG	2024/01/05	Authorised
Stelara	Human	ustekinumab	ustekinumab	EMEA/H/C/000958	Janssen-Cilag International NV	2009/01/15	Authorised
Yesintek	Human	ustekinumab	ustekinumab	EMEA/H/C/006444	Biosimilar Collaborations Ireland Limited		Opinion
Upstelda	Human	ustekinumab	ustekinumab	EMEA/H/C/006415	Amgen Technology (Ireland) UC		Application withdrawn

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-